LEXX Annual ROE
-112.11%
+17.15%+13.27%
31 August 2024
Summary:
As of January 23, 2025, LEXX annual return on equity is -112.11%, with the most recent change of +17.15% (+13.27%) on August 31, 2024. During the last 3 years, it has fallen by -60.30% (-116.39%). LEXX annual ROE is now -1513.09% below its all-time high of -6.95%, reached on October 31, 2005.LEXX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEXX Quarterly ROE
-100.77%
-2.90%-2.96%
30 November 2024
Summary:
As of January 23, 2025, LEXX quarterly return on equity is -100.77%, with the most recent change of -2.90% (-2.96%) on November 30, 2024. Over the past year, it has dropped by -7.46% (-7.99%). LEXX quarterly ROE is now -6320.37% below its all-time high of 1.62%, reached on July 31, 2008.LEXX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEXX ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +13.3% | -8.0% |
3 y3 years | -116.4% | -29.4% |
5 y5 years | +33.3% | -29.4% |
LEXX ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -116.4% | +13.3% | -82.9% | +31.6% |
5 y | 5-year | -116.4% | +33.3% | -96.8% | +36.7% |
alltime | all time | -1513.1% | +65.7% | -6320.4% | +82.1% |
Lexaria Bioscience ROE History
Date | Annual | Quarterly |
---|---|---|
Nov 2024 | - | -100.77%(+3.0%) |
Aug 2024 | -112.11%(-13.3%) | -97.87%(+4.9%) |
May 2024 | - | -93.31%(-28.4%) |
Feb 2024 | - | -130.30%(-11.6%) |
Nov 2023 | - | -147.36%(+10.2%) |
Aug 2023 | -129.26%(+84.0%) | -133.74%(+20.9%) |
May 2023 | - | -110.64%(+22.8%) |
Feb 2023 | - | -90.07%(+15.7%) |
Nov 2022 | - | -77.85%(+12.0%) |
Aug 2022 | -70.25%(+35.6%) | -69.50%(+9.4%) |
May 2022 | - | -63.53%(+2.5%) |
Feb 2022 | - | -61.97%(+12.5%) |
Nov 2021 | - | -55.09%(+7.6%) |
Aug 2021 | -51.81%(-67.3%) | -51.19%(-17.9%) |
May 2021 | - | -62.34%(+6.3%) |
Feb 2021 | - | -58.66%(-63.1%) |
Nov 2020 | - | -159.16%(+0.1%) |
Aug 2020 | -158.22%(-5.8%) | -159.08%(+0.4%) |
May 2020 | - | -158.51%(+9.0%) |
Feb 2020 | - | -145.38%(+5.5%) |
Nov 2019 | - | -137.82%(+3.5%) |
Aug 2019 | -168.05%(-34.3%) | -133.17%(-2.3%) |
May 2019 | - | -136.37%(-37.0%) |
Feb 2019 | - | -216.58%(-12.3%) |
Nov 2018 | - | -246.87%(-3.0%) |
Aug 2018 | -255.97%(+95.5%) | -254.44%(+14.4%) |
May 2018 | - | -222.50%(+71.4%) |
Feb 2018 | - | -129.80%(+18.2%) |
Nov 2017 | - | -109.85%(-17.4%) |
Aug 2017 | -130.92%(-59.9%) | -132.97%(-25.1%) |
May 2017 | - | -177.52%(-68.4%) |
Feb 2017 | - | -561.10%(-0.4%) |
Nov 2016 | - | -563.35%(+4.2%) |
Aug 2016 | -326.40%(+118.8%) | -540.89%(+65.9%) |
May 2016 | - | -326.09%(+36.0%) |
Feb 2016 | - | -239.84%(+24.8%) |
Nov 2015 | - | -192.22%(+71.4%) |
Aug 2015 | -149.18% | -112.15%(+34.6%) |
May 2015 | - | -83.30%(+6.6%) |
Date | Annual | Quarterly |
---|---|---|
Feb 2015 | - | -78.17%(+33.2%) |
Nov 2014 | - | -58.68%(+24.1%) |
Aug 2014 | -170.74%(+1023.3%) | - |
July 2014 | - | -47.29%(+49.8%) |
Apr 2014 | - | -31.56%(+106.8%) |
Jan 2014 | - | -15.26%(+0.5%) |
Oct 2013 | -15.20%(+53.5%) | -15.18%(+89.5%) |
July 2013 | - | -8.01%(+211.7%) |
Apr 2013 | - | -2.57%(-74.8%) |
Jan 2013 | - | -10.20%(+0.1%) |
Oct 2012 | -9.90%(-55.7%) | -10.19%(-11.1%) |
July 2012 | - | -11.46%(-55.0%) |
Apr 2012 | - | -25.44%(+12.0%) |
Jan 2012 | - | -22.71%(-5.5%) |
Oct 2011 | -22.36%(-9.9%) | -24.02%(-16.2%) |
July 2011 | - | -28.68%(+53.7%) |
Apr 2011 | - | -18.66%(+2.1%) |
Jan 2011 | - | -18.28%(-26.1%) |
Oct 2010 | -24.82%(-16.7%) | -24.73%(-11.8%) |
July 2010 | - | -28.05%(-20.4%) |
Apr 2010 | - | -35.23%(-2.4%) |
Jan 2010 | - | -36.09%(+20.0%) |
Oct 2009 | -29.79%(-6.3%) | -30.08%(-11.7%) |
July 2009 | - | -34.07%(+23.1%) |
Apr 2009 | - | -27.67%(-24.9%) |
Jan 2009 | - | -36.84%(+15.9%) |
Oct 2008 | -31.78%(-38.3%) | -31.78%(-2061.7%) |
July 2008 | - | 1.62%(-104.6%) |
Apr 2008 | - | -35.29%(+15.5%) |
Jan 2008 | - | -30.55%(-33.0%) |
Oct 2007 | -51.51%(-9.1%) | -45.63%(-57.0%) |
July 2007 | - | -106.07%(+61.6%) |
Apr 2007 | - | -65.62%(+19.4%) |
Jan 2007 | - | -54.95%(+9.1%) |
Oct 2006 | -56.67%(+715.4%) | -50.36%(+411.8%) |
July 2006 | - | -9.84%(+92.2%) |
Apr 2006 | - | -5.12%(+105.6%) |
Jan 2006 | - | -2.49% |
Oct 2005 | -6.95% | - |
FAQ
- What is Lexaria Bioscience annual return on equity?
- What is the all time high annual ROE for Lexaria Bioscience?
- What is Lexaria Bioscience annual ROE year-on-year change?
- What is Lexaria Bioscience quarterly return on equity?
- What is the all time high quarterly ROE for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly ROE year-on-year change?
What is Lexaria Bioscience annual return on equity?
The current annual ROE of LEXX is -112.11%
What is the all time high annual ROE for Lexaria Bioscience?
Lexaria Bioscience all-time high annual return on equity is -6.95%
What is Lexaria Bioscience annual ROE year-on-year change?
Over the past year, LEXX annual return on equity has changed by +17.15% (+13.27%)
What is Lexaria Bioscience quarterly return on equity?
The current quarterly ROE of LEXX is -100.77%
What is the all time high quarterly ROE for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly return on equity is 1.62%
What is Lexaria Bioscience quarterly ROE year-on-year change?
Over the past year, LEXX quarterly return on equity has changed by -7.46% (-7.99%)